ARTICLE SUMMARY:
Malignant pleural effusion is a side effect of several prevalent cancers that causes fluid to accumulate in the chest cavity, limiting the expansion of the lungs and causing breathlessness, anxiety, and chest pain. While some drainage devices exist to alleviate this condition, SymPhysis Medical has engineered the first device that patients can use autonomously, restoring independence to their life.
The city of Galway, Ireland is a known hotbed of medtech business development and is home to a multitude of innovative medical device companies including SymPhysis Medical Ltd., a start-up with a patient-centric solution to malignant pleural effusion (MPE). MPE is a complication associated with cancers of the thorax area such as breast and lung cancer, mesothelioma, and lymphoma, occurring in roughly 15% of combined cases and 50% of all metastatic cancers.
